Identification of virulence factors in cerebral malaria in Benin
Gwladys Bertin is interested to facilitate the identification of variants associated to cerebral malaria in the proteomic analysis. She is correlating proteomic data from cerebral malaria samples with whole genome sequencing of these samples. The whole genome sequencing will allow adding new sequences and to facilitate the identification of variants associated to cerebral malaria in the proteomic analysis.The aim of this study is to correlate proteomic data from cerebral malaria samples with whole genome sequencing of these samples. The data from the whole genome sequencing will be used for analysis of proteomic and RNA-sequencing. The whole genome sequencing will allow adding new sequences and to facilitate the identification of variants associated to cerebral malaria in the proteomic analysis.
Summary
- 334 Samples
- 2 Locations
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Locations
Atlantique
Summary
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Littoral
Summary
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers